Pancreatic Cancer
Conditions
Interventions
Blood collection: Approximately 2 ml of blood is collected in healthy control case.
Blood collection: Approximately 2 ml of blood is collected in pancreatic cancer case.
Sponsors
Kyoto University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy Control Cases Cases that meet all of the following criteria: - Age between 40 and 85 years inclusive - Written informed consent obtained from the individual for participation in this study Pancreatic Cancer Cases Cases that meet all of the following criteria: - Age between 40 and 85 years inclusive - Written informed consent obtained from the individual for participation in this study - Registered in the separate trial titled "Investigation of Hypoxic Regions and the Effectiveness of Radiotherapy in Pancreatic Cancer (C1491-1)"
Exclusion criteria
Exclusion criteria: Cases that meet any of the following criteria will be excluded from this study: - History of malignant tumors - Cases deemed inappropriate by the principal investigator or co-investigators due to medical or other factors (e.g., poor general condition)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The utility of plasma SPINK1 concentration in predicting the presence of pancreatic cancer | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The sensitivity and specificity of plasma SPINK1 levels for predicting pancreatic cancer, along with an appropriate threshold setting 2. The association between Plasma SPINK1 levels and patient background factors (age, gender, BMI) | — |
Countries
Japan
Contacts
Public ContactTatsuya Suwa
Kyoto University Hospital Department of Radiation Oncology and Image-applied Therapy
Outcome results
None listed